NCT06262607View on ClinicalTrials.gov

A Study of CLE-400 (Topical Gel) for the Treatment of Chronic Pruritus in Adult Subjects With Notalgia Paresthetica

PHASE2CompletedINTERVENTIONAL
Enrollment

59

Participants

Timeline

Start Date

January 29, 2024

Primary Completion Date

November 6, 2024

Study Completion Date

November 19, 2024

Conditions
Chronic Pruritus in Adult Subjects With Notalgia Paresthetica (NP)
Interventions
DRUG

CLE-400

Topical CLE400 gel 0.28% administered once daily

DRUG

Vehicle

Topical vehicle gel administered once daily

Trial Locations (13)

10028

Clinical Site 15, New York

27262

Clinical site 03, High Point

33063

Clinical Site 13, Margate

33116

Clinical Site 10, North Miami Beach

33134

Clinical site 01, Coral Gables

43016

Clinical Site 09, Dublin

46250

Clinical Site 02, Indianapolis

72022

Clinical site 11, Bryant

77004

Clinical site 16, Houston

78213

Clinical Site 06, San Antonio

94538

Clinical Site 21, Fremont

01844

Clinical Site 23, Methuen

03801

Clinical Site 20, Portsmouth

Sponsors
All Listed Sponsors
lead

Clexio Biosciences Ltd.

INDUSTRY

NCT06262607 - A Study of CLE-400 (Topical Gel) for the Treatment of Chronic Pruritus in Adult Subjects With Notalgia Paresthetica | Biotech Hunter | Biotech Hunter